These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 15947065)
1. Motor reorganization in asymptomatic carriers of a single mutant Parkin allele: a human model for presymptomatic parkinsonism. Buhmann C; Binkofski F; Klein C; Büchel C; van Eimeren T; Erdmann C; Hedrich K; Kasten M; Hagenah J; Deuschl G; Pramstaller PP; Siebner HR Brain; 2005 Oct; 128(Pt 10):2281-90. PubMed ID: 15947065 [TBL] [Abstract][Full Text] [Related]
2. Mapping preclinical compensation in Parkinson's disease: an imaging genomics approach. van Nuenen BF; van Eimeren T; van der Vegt JP; Buhmann C; Klein C; Bloem BR; Siebner HR Mov Disord; 2009; 24 Suppl 2():S703-10. PubMed ID: 19877238 [TBL] [Abstract][Full Text] [Related]
3. Compensatory premotor activity during affective face processing in subclinical carriers of a single mutant Parkin allele. Anders S; Sack B; Pohl A; Münte T; Pramstaller P; Klein C; Binkofski F Brain; 2012 Apr; 135(Pt 4):1128-40. PubMed ID: 22434215 [TBL] [Abstract][Full Text] [Related]
4. Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype. van Nuenen BF; Weiss MM; Bloem BR; Reetz K; van Eimeren T; Lohmann K; Hagenah J; Pramstaller PP; Binkofski F; Klein C; Siebner HR Neurology; 2009 Mar; 72(12):1041-7. PubMed ID: 19038850 [TBL] [Abstract][Full Text] [Related]
5. Motor cortical physiology in patients and asymptomatic carriers of parkin gene mutations. Schneider SA; Talelli P; Cheeran BJ; Khan NL; Wood NW; Rothwell JC; Bhatia KP Mov Disord; 2008 Oct; 23(13):1812-9. PubMed ID: 18759365 [TBL] [Abstract][Full Text] [Related]
6. Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia. Binkofski F; Reetz K; Gaser C; Hilker R; Hagenah J; Hedrich K; van Eimeren T; Thiel A; Büchel C; Pramstaller PP; Siebner HR; Klein C Neurology; 2007 Aug; 69(9):842-50. PubMed ID: 17724286 [TBL] [Abstract][Full Text] [Related]
7. Abnormal premotor-motor interaction in heterozygous Parkin- and Pink1 mutation carriers. Weissbach A; Bäumer T; Pramstaller PP; Brüggemann N; Tadic V; Chen R; Klein C; Münchau A Clin Neurophysiol; 2017 Jan; 128(1):275-280. PubMed ID: 27843055 [TBL] [Abstract][Full Text] [Related]
8. Sensorimotor integration is abnormal in asymptomatic Parkin mutation carriers: a TMS study. Bäumer T; Pramstaller PP; Siebner HR; Schippling S; Hagenah J; Peller M; Gerloff C; Klein C; Münchau A Neurology; 2007 Nov; 69(21):1976-81. PubMed ID: 18025391 [TBL] [Abstract][Full Text] [Related]
9. Eye movement disorders are different in Parkin-linked and idiopathic early-onset PD. Machner B; Klein C; Sprenger A; Baumbach P; Pramstaller PP; Helmchen C; Heide W Neurology; 2010 Jul; 75(2):125-8. PubMed ID: 20625164 [TBL] [Abstract][Full Text] [Related]
10. Responsiveness to distracting stimuli, though increased in Parkinson's disease, is decreased in asymptomatic PINK1 and Parkin mutation carriers. Verleger R; Hagenah J; Weiss M; Ewers T; Heberlein I; Pramstaller PP; Siebner HR; Klein C Neuropsychologia; 2010 Jan; 48(2):467-76. PubMed ID: 19822161 [TBL] [Abstract][Full Text] [Related]
11. Imaging movement-related activity in medicated Parkin-associated and sporadic Parkinson's disease. van Eimeren T; Binkofski F; Buhmann C; Hagenah J; Strafella AP; Pramstaller PP; Siebner HR; Klein C Parkinsonism Relat Disord; 2010 Jul; 16(6):384-7. PubMed ID: 20434937 [TBL] [Abstract][Full Text] [Related]
12. Intracerebral ERD/ERS in voluntary movement and in cognitive visuomotor task. Rektor I; Sochůrková D; Bocková M Prog Brain Res; 2006; 159():311-30. PubMed ID: 17071240 [TBL] [Abstract][Full Text] [Related]
13. Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson's disease: contribution of automated segmentation neuroimaging method. Bilgic B; Bayram A; Arslan AB; Hanagasi H; Dursun B; Gurvit H; Emre M; Lohmann E Parkinsonism Relat Disord; 2012 Jun; 18(5):562-6. PubMed ID: 22445249 [TBL] [Abstract][Full Text] [Related]
14. Movement-related potentials in Parkinson's disease. Presence and predictability of temporal and spatial cues. Cunnington R; Iansek R; Bradshaw JL; Phillips JG Brain; 1995 Aug; 118 ( Pt 4)():935-50. PubMed ID: 7655889 [TBL] [Abstract][Full Text] [Related]
15. Levodopa reinstates connectivity from prefrontal to premotor cortex during externally paced movement in Parkinson's disease. Herz DM; Siebner HR; Hulme OJ; Florin E; Christensen MS; Timmermann L Neuroimage; 2014 Apr; 90():15-23. PubMed ID: 24269570 [TBL] [Abstract][Full Text] [Related]
16. Costs of control: decreased motor cortex engagement during a Go/NoGo task in Tourette's syndrome. Thomalla G; Jonas M; Bäumer T; Siebner HR; Biermann-Ruben K; Ganos C; Orth M; Hummel FC; Gerloff C; Müller-Vahl K; Schnitzler A; Münchau A Brain; 2014 Jan; 137(Pt 1):122-36. PubMed ID: 24176975 [TBL] [Abstract][Full Text] [Related]
17. Effective connectivity of brain networks during self-initiated movement in Parkinson's disease. Wu T; Wang L; Hallett M; Chen Y; Li K; Chan P Neuroimage; 2011 Mar; 55(1):204-15. PubMed ID: 21126588 [TBL] [Abstract][Full Text] [Related]
18. Influence of L-dopa on subtle motor signs in heterozygous Parkin- and PINK1 mutation carriers. Weissbach A; König IR; Hückelheim K; Pramstaller PP; Werner E; Brüggemann N; Tadic V; Lohmann K; Bäumer T; Münchau A; Kasten M; Klein C Parkinsonism Relat Disord; 2017 Sep; 42():95-99. PubMed ID: 28716427 [TBL] [Abstract][Full Text] [Related]